trolamine salicylate has been researched along with Erythema Migrans, Lingual in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czupryna, P; Dunaj, J; Guziejko, K; Moniuszko, A; Pancewicz, S; Zajkowska, J | 1 |
| Anselmo, A; Arvikar, SL; Crowley, JT; Pianta, A; Sadreyev, R; Steere, AC; Strle, K; Sulka, KB | 1 |
1 review(s) available for trolamine salicylate and Erythema Migrans, Lingual
| Article | Year |
|---|---|
[Erythema migrans as a patognomic symptom of lyme disease].
Topics: Anti-Bacterial Agents; Arthritis; Diagnosis, Differential; Glossitis, Benign Migratory; Humans; Lyme Disease | 2013 |
1 other study(ies) available for trolamine salicylate and Erythema Migrans, Lingual
| Article | Year |
|---|---|
T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.
Topics: Adaptive Immunity; Antibodies, Bacterial; Arthritis; Autoantibodies; Autoantigens; Autoimmunity; Biomarkers; Borrelia burgdorferi; Cytokines; Female; Glossitis, Benign Migratory; Humans; Immunity, Innate; Inflammation Mediators; Lyme Disease; Male; Th17 Cells | 2017 |